Philips has grown the unit’s peripheral vascular portfolio through acquisition. The Vesper takeover happened around 15 months after Philips disclosed the acquisition of Intact Vascular. Buying Intact ...

Masimo will have to juggle the government inquiries while also dealing with an activist investor-led proxy battle.

J.P. Morgan analysts said the move is a “low cost way of adding more robotic options” for Zimmer, but they were still unsure about the added value of the partnership.

Around two-thirds of the trials studied cardiovascular diseases. Another one-fifth of the studies tested orthopedic products. Women made up a median of 29% of the participants in cardiovascular ...

Kardium will use the funding to complete a clinical study for pursuing regulatory approvals and build its manufacturing, clinical support and commercial teams.

Abbott is recalling a system monitor used with the Heartmate cardiac pump because screen display issues could pose a risk to patients. The Class 1 recall affects 4,842 ...

Boston Scientific is forecast to gain the largest share of the U.S. ablation catheter market in the next 12 months, at the expense of Abbott and J&J.

Marcus Schabacker called for more upfront regulations and postmarket monitoring to better understand how AI features affect patient care.

Martin Stumpe will take over the new position after previously working as Tempus’ chief of AI and the head of Google’s pathology team.

A problem with the Stealthstation S8 could cause incorrect device placement during surgery. It is the fourth recall of Stealthstation software in the past 12 months.

Data presented at the American Society of Clinical Oncology meeting suggest the test can support prostate cancer diagnosis in people who are missed by other screening methods.

Apple Watch and G7 users can now view real-time glucose readings on their wrist, regardless of whether they are carrying an iPhone.